Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Jade Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- −4 vs. Q4 2022
- Shares held
- 26.0M
- −1.42M (−5.2%) vs. Q4 2022
- Total value
- $524.1M
- −$278.8M (−34.7%) vs. Q4 2022
- New holders
- 6
- 23 more added
- Sold out
- 10
- 25 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $166.7M | 3.77% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $75.8M | 5.14% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $41.1M | 5.57% | +21,728+1.1% | Added |
| Baker Bros. Advisors LP | 1,963,479 | $39.6M | 0.22% | −13,389−0.7% | Reduced |
| Cormorant Asset Management, LP | 1,561,696 | $31.5M | 2.07% | −395,436−20.2% | Reduced |
| TCG Crossover Management, LLC | 1,081,274 | $21.8M | 4.25% | 00.0% | Unchanged |
| VR Adviser, LLC | 833,927 | $16.8M | 3.28% | +86,058+11.5% | Added |
| OrbiMed Advisors LLC | 756,930 | $15.3M | 0.30% | −2,610−0.3% | Reduced |
| Great Point Partners LLC | 755,620 | $15.2M | 3.01% | +377,098+99.6% | Added |
| Octagon Capital Advisors LP | 621,712 | $12.5M | 1.81% | 00.0% | Unchanged |
| OUP Management Co., LLC | 603,762 | $12.2M | 24.30% | 00.0% | Unchanged |
| BlackRock Inc. | 599,999 | $12.1M | 0.00% | −7,984−1.3% | Reduced |
| FMR LLC | 570,965 | $11.5M | 0.00% | +113,778+24.9% | Added |
| Vanguard Group Inc | 513,312 | $10.4M | 0.00% | +13,835+2.8% | Added |
| Frazier Life Sciences Management, L.P. | 338,110 | $6.82M | 0.49% | +338,110 | New |
| Ghost Tree Capital, LLC | 200,000 | $4.03M | 1.53% | +65,000+48.1% | Added |
| Ikarian Capital, LLC | 195,146 | $3.94M | 1.63% | +67,225+52.6% | Added |
| Geode Capital Management, LLC | 187,499 | $3.78M | 0.00% | +8,903+5.0% | Added |
| State Street Corp | 184,593 | $3.72M | 0.00% | −7,591−3.9% | Reduced |
| Fred Alger Management, LLC | 104,048 | $2.10M | 0.01% | −43,907−29.7% | Reduced |
| Nantahala Capital Management, LLC | 95,000 | $1.92M | 0.18% | +79,300+505.1% | Added |
| Northern Trust Corp | 77,439 | $1.56M | 0.00% | −760−1.0% | Reduced |
| Point72 Asset Management, L.P. | 69,119 | $1.39M | 0.00% | −105,903−60.5% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $1.03M | 0.01% | −2,474−4.6% | Reduced |
| Eversept Partners, LP | 50,242 | $1.01M | 0.09% | −41,010−44.9% | Reduced |
| Nan Fung Group Holdings Ltd | 47,936 | $966.9K | 0.66% | −2,680−5.3% | Reduced |
| Morgan Stanley | 44,974 | $907.1K | 0.00% | +42,784+1,953.6% | Added |
| Boothbay Fund Management, LLC | 39,573 | $798.2K | 0.02% | +13,760+53.3% | Added |
| Nuveen Asset Management, LLC | 36,310 | $732.0K | 0.00% | −802−2.2% | Reduced |
| Bank of New York Mellon Corp | 27,795 | $560.6K | 0.00% | −299−1.1% | Reduced |
| Parkwood LLC | 25,863 | $522.0K | 0.10% | +5,303+25.8% | Added |
| Charles Schwab Investment Management Inc | 24,641 | $497.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 20,792 | $419.0K | 0.00% | −102,416−83.1% | Reduced |
| Swiss National Bank | 18,601 | $375.2K | 0.00% | −2,100−10.1% | Reduced |
| Renaissance Technologies LLC | 17,600 | $355.0K | 0.00% | −500−2.8% | Reduced |
| Alps Advisors Inc | 16,208 | $326.9K | 0.00% | −477−2.9% | Reduced |
| D. E. Shaw & Co., Inc. | 15,958 | $321.9K | 0.00% | −13,536−45.9% | Reduced |
| HighVista Strategies LLC | 15,833 | $319.4K | 0.26% | +15,833 | New |
| Ensign Peak Advisors, Inc | 15,000 | $302.6K | 0.00% | −6,208−29.3% | Reduced |
| Rhumbline Advisers | 14,798 | $298.0K | 0.00% | +566+4.0% | Added |
| Bank of America Corp | 13,302 | $268.3K | 0.00% | +5,746+76.0% | Added |
| Trustees of Columbia University in the City of New York | 13,190 | $266.0K | 0.48% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 11,614 | $234.3K | 0.00% | +11,614 | New |
| Two Sigma Investments, LP | 11,509 | $232.1K | 0.00% | −9,628−45.6% | Reduced |
| California State Teachers Retirement System | 10,959 | $221.0K | 0.00% | −122−1.1% | Reduced |
| Golden State Equity Partners | 10,530 | $212.4K | 0.11% | +10,530 | New |
| New York State Common Retirement Fund | 7,684 | $155.0K | 0.00% | +11+0.1% | Added |
| JPMorgan Chase & Co | 7,084 | $143.0K | 0.00% | +1,817+34.5% | Added |
| UBS Group AG | 5,986 | $120.7K | 0.00% | +5,986 | New |
| Deutsche Bank AG | 5,639 | $113.7K | 0.00% | +1,857+49.1% | Added |
| MetLife Investment Management | 5,228 | $105.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 4,720 | $95.2K | 0.00% | +850+22.0% | Added |
| American International Group, Inc. | 4,432 | $89.4K | 0.00% | +88+2.0% | Added |
| Legal & General Group Plc | 3,431 | $69.2K | 0.00% | +196+6.1% | Added |
| Tower Research Capital LLC (TRC) | 2,702 | $55.0K | 0.00% | +1,558+136.2% | Added |
| STRS Ohio | 2,300 | $46.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,636 | $33.0K | 0.00% | +1,636 | New |
| Amalgamated Bank | 987 | $20.0K | 0.00% | −212−17.7% | Reduced |
| Russell Investments Group, Ltd. | 939 | $18.9K | 0.00% | −236−20.1% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $15.6K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $14.1K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 515 | $10.0K | 0.00% | −983−65.6% | Reduced |
| Citigroup Inc | 229 | $4.62K | 0.00% | −120−34.4% | Reduced |
| Federated Hermes, Inc. | 202 | $4.07K | 0.00% | +118+140.5% | Added |
| Ellevest, Inc. | 7 | $141 | 0.00% | +4+133.3% | Added |
| Nisa Investment Advisors, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,561,923−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −217,119−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −72,579−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −36,906−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −18,927−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −13,225−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9,071−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −8,567−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −8,092−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −3,206−100.0% | Sold out |